Serum Vitamin D Levels in Relation to Metabolic Syndrome: A Systematic Review and Dose–Response Meta-Analysis of Epidemiologic Studies Publisher Pubmed



Hajhashemy Z¹ ; Shahdadian F¹ ; Moslemi E² ; Mirenayat FS¹ ; Saneei P¹ Show Affiliations
Source: Obesity Reviews Published:2021

Abstract

Several epidemiological studies examined the association of serum vitamin D with metabolic syndrome (MetS), but the findings were inconsistent. We conducted a systematic review and dose–response meta-analysis to quantify the association between blood vitamin D levels and MetS in adults. A systematic search up to December 2020 was conducted in MEDLINE (PubMed), ISI (Web of Science), Scopus, and Google Scholar databases for epidemiological studies that assessed the relation of serum 25-hydroxyvitamin D (as the exposure) and MetS (as the outcome) in adults. Eligible cross-sectional studies were restricted to those with representative populations. Finally, 43 studies were included in the analysis (38 cross-sectional, one nested case–control, and four cohorts studies). Combining 41 effect sizes from 38 cross-sectional studies included 298,187 general adult population revealed that the highest level of serum vitamin D, compared with the lowest level, was significantly related to a 43% decreased odds of MetS in developed countries (odds ratio [OR]: 0.57; 95% confidence interval [CI]: 0.49–0.65) and 40% in developing countries (OR: 0.60; 95% CI: 0.52–0.70). Linear dose–response analysis (including 222,175 healthy individuals and 39,308 MetS patients) revealed that each 25 nmol/L increase in serum vitamin D level was significantly associated with a 15% decreased odds of MetS (OR: 0.85; 95% CI: 0.80–0.91); however, we found no significant nonlinear association. Meta-analysis of five prospective studies with 11,019 participants revealed no significant relation (relative risk [RR]: 0.70; 95% CI: 0.37–1.32). This meta-analysis indicated an inverse association between serum vitamin D concentrations and risk of MetS in general adult populations in cross-sectional studies in a dose–response manner. However, no significant association was found in a small number of cohorts. More prospective studies are needed to confirm the causality of this relationship. © 2021 World Obesity Federation